MalarVx Analysis: $2M Raised
What is MalarVx?
MalarVx focuses on developing vaccines to combat malaria, a disease that claims a child's life every two minutes. The company addresses the significant challenge posed by malaria through innovative research and development efforts. Their work aims to create effective solutions to eliminate malaria's impact on global health.
Location
307 Westlake Ave N, Seattle, Washington 98109, United States
Employees
1-10
Founded
2012
Funding Status
Not Funded
Product Features & Capabilities
- Vaccine development
- In vitro mosquito-stages research
- Clinical trials pipeline
- Scientific publications
Use Cases
Develop vaccines targeting malaria; Conduct clinical trials for vaccine efficacy; Research mosquito stages to inform vaccine design; Publish findings to advance malaria research; Collaborate with health organizations for malaria eradication
See something that needs updating? Suggest edits to this profile.